Men's Health News

RSS

Third dose of mRNA COVID vaccine induces strong immunity in older adults

A new study describes the beneficial effects of a third dose of the COVID-19 mRNA vaccine in strengthening immunity among older adults.

11 Jan 2022

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

A new study posted to the pre-print server medRxiv* investigated the significant immune alterations concerning SARS-CoV-2 specific innate and adaptive immunity associated with a lower BNT162b2 mRNA vaccine response in older individuals.

10 Jan 2022

A study on COVID vaccinated vs. unvaccinated that required hospitalization

Researchers compared the characteristics of fully vaccinated and boosted and unvaccinated patients requiring hospitalization for COVID-19.

10 Jan 2022

New genetic mechanism that can cause severe male infertility identified

Scientists at Newcastle University have identified a new genetic mechanism that can cause severe forms of male infertility.

10 Jan 2022

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

The Society of Nuclear Medicine and Molecular Imaging and peer medical groups have issued appropriate use criteria (AUC) for prostate-specific membrane antigen (PSMA) PET imaging.

7 Jan 2022

How diet, supplements and lifestyle changes can help battle COVID

A recent editorial in the journal Nutrients emphasizes how efficacious non-pharmacological interventions in conjunction with the promotion of healthy lifestyle and dietary patterns may improve overall health status and reduce the risk of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the potential adverse effects of coronavirus disease 2019 (COVID-19).

6 Jan 2022

Malta as a primer for rapid and effective COVID-19 vaccination strategy

A research paper recently published in the journal Health Sciences Review shows how high vaccine availability and low population vaccination hesitancy were two pivotal factors for the successful control of coronavirus disease 2019 (COVID-19) in Malta, Europe.

6 Jan 2022

Time since COVID vaccination is a key driver of breakthrough Omicron infections

Published on the preprint medRxiv* server and awaiting peer review, the findings showed that the significant factor behind breakthrough Omicron infections is the timing from vaccination. The time between vaccination and breakthrough infections induced effective or cross-reactive neutralizing antibodies that neutralize Omicron after Alpha or Delta breakthrough infections.

4 Jan 2022

New study on NAbs against SARS-CoV-2 Omicron variant after vaccination or infection

A recent study suggests neutralizing antibody responses against variants of concern, including Omicron, differs significantly between vaccinated and naturally infected individuals. The research, posted to the medRxiv* preprint server, focused on vaccinated individuals who are pregnant — an understudied group in COVID-19 research.

4 Jan 2022

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

Researcers determine the risk of symptomatic and asymptomatic SARS-CoV-2 infection on post-acute cardiovascular events and all-cause mortality.

4 Jan 2022

Exposure to parasitic roundworm linked with lower lung-function and asthma in younger men

By looking at the exposure to the parasitic roundworm Ascaris lumbricoides/suum in Nothern Europe (Norway, Denmark and Estonia), the study finds that younger men exposed to Ascaris had a striking reduction in lung function and nearly five times higher odds of having asthma compared to the non-exposed.

4 Jan 2022

A closer look at the relationship between COVID-19 and Alzheimer’s disease

Researchers discuss the findings of previous studies on the role of SARS-CoV-2 infection in the progression of Alzheimer's Disease.

4 Jan 2022

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

Researchers investigate the neutralizing antibody activity against different variants of SARS-CoV-2 in fully immunized elderly individuals.

3 Jan 2022

Loss of smell is the best predictor of COVID-19

A large international team of researchers has conducted a crowdsourced cross-sectional study, in which they have investigated the reliability of the olfactory loss (or loss of smell, or anosmia) as a predictor of coronavirus disease 19 (COVID-19).

30 Dec 2021

Black men with prostate cancer may have improved response to radiation therapy than white men

UCLA Jonsson Comprehensive Cancer Center researchers leading a meta-analysis of seven randomized trials found an "unexpected result": Although Black men appeared to have more aggressive disease when they enrolled in clinical trials of radiation therapy for prostate cancer, their treatment outcomes and disease-specific outcomes were better than those of their white counterparts.

30 Dec 2021

COVID can affect sperm quality for three months

Researchers determine whether SARS-CoV-2 could cross the blood-testis barrier and be detected in human semen after infection.

22 Dec 2021

Middle-aged men living in rural counties in the US have higher heart attack death rates than women

Middle-aged adults, men, Black adults and adults living in rural counties have significantly higher heart attack death rates before the age of 65 compared to women, white adults and people living in urban counties, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

22 Dec 2021

Researchers identify novel cancer markers in patients with aggressive prostate cancer

Prostate cancer is the most commonly diagnosed cancer in men and is among the top five causes of cancer-related death. In most cases, prostate cancer can be successfully treated but there is a group of patients who suffer an aggressive course and often fatal outcome.

22 Dec 2021

National U.S trial confirms effectiveness of mRNA COVID-19 vaccines

In a recent study, published in the Annals of Internal Medicine, scientists conducted a target trial emulation study and documented that among the elderly in the U.S. (with significant comorbidities), the efficacy of messenger RNA (mRNA) vaccines was much lower in terms of preventing infection, than previously reported. However, the effectiveness against death was found to be high.

21 Dec 2021

Risk of exposure to SARS-CoV-2 by workplace and trade

Researchers investigate the risk of SARS-CoV-2 exposure to people in workplaces across different occupations over time.

21 Dec 2021

Men's Health News

Third dose of mRNA COVID vaccine induces strong immunity in older adults

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

A study on COVID vaccinated vs. unvaccinated that required hospitalization

New genetic mechanism that can cause severe male infertility identified

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

How diet, supplements and lifestyle changes can help battle COVID

Malta as a primer for rapid and effective COVID-19 vaccination strategy

Time since COVID vaccination is a key driver of breakthrough Omicron infections

New study on NAbs against SARS-CoV-2 Omicron variant after vaccination or infection

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

Exposure to parasitic roundworm linked with lower lung-function and asthma in younger men

A closer look at the relationship between COVID-19 and Alzheimer’s disease

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

Loss of smell is the best predictor of COVID-19

Black men with prostate cancer may have improved response to radiation therapy than white men

COVID can affect sperm quality for three months

Middle-aged men living in rural counties in the US have higher heart attack death rates than women

Researchers identify novel cancer markers in patients with aggressive prostate cancer

National U.S trial confirms effectiveness of mRNA COVID-19 vaccines

Risk of exposure to SARS-CoV-2 by workplace and trade

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News